Sildenafil citrate as a phosphodiesterase inhibitor has an antioxidant effect in the blood of men - Perk, H.; Armagan, A.; Nazıroğlu, M.; Soyupek, S.; Hoscan, M. B.; Sütcü, R.; Ozorak, A.; Delibas, N. (Journal of clinical pharmacy and therapeutics, 2008)
Keywords: Adult; antioxidant redox system; Antioxidants - pharmacology; Biological and medical sciences; Catalase - drug effects; Catalase - metabolism; Cyclic GMP - metabolism; Humans; Lipid Peroxidation - drug effects; Male; Medical sciences; Nitric Oxide - metabolism; Oxidation-Reduction - drug effects; oxidative stress; Oxidative Stress - drug effects; Pharmacology. Drug treatments; phosphodiesterase inhibitors; Phosphodiesterase Inhibitors - pharmacology; Piperazines - pharmacology; Purines - pharmacology; Sildenafil Citrate; Sulfones - pharmacology; Superoxide Dismutase - drug effects; Superoxide Dismutase - metabolism; Time Factors; vitamin E; Young Adult; Human; Biological fluid; Oxidative stress; Vasodilator agent; 3',5'-Cyclic-GMP phosphodiesterase; Enzyme; Enzyme inhibitor; Male; Esterases; Phosphoric diester hydrolases; Antioxidant; sildenafil citrate; Blood; Phosphodiesterase 5 inhibitor; Phosphodiesterase inhibitor; antioxidant redox system; Vitamin E; Hydrolases; Adult; Sildenafil; Redox system; phosphodiesterase inhibitors